IVAX CORP /DE
10-Q, EX-27, 2000-11-07
PHARMACEUTICAL PREPARATIONS
Previous: IVAX CORP /DE, 10-Q, EX-10.19(B), 2000-11-07
Next: IVAX CORP /DE, S-3/A, 2000-11-07



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
         THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM IVAX
         CORPORATION'S FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30,
         2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
         STATEMENTS.
</LEGEND>
<MULTIPLIER>                                   1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              DEC-31-1999
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   SEP-30-2000
<CASH>                                             262,770
<SECURITIES>                                             0
<RECEIVABLES>                                      129,147
<ALLOWANCES>                                        20,950
<INVENTORY>                                        180,747
<CURRENT-ASSETS>                                   597,708
<PP&E>                                             389,521
<DEPRECIATION>                                     156,191
<TOTAL-ASSETS>                                     993,841
<CURRENT-LIABILITIES>                              192,336
<BONDS>                                            250,000
                                    0
                                              0
<COMMON>                                            15,945
<OTHER-SE>                                         485,345
<TOTAL-LIABILITY-AND-EQUITY>                       993,841
<SALES>                                            483,655
<TOTAL-REVENUES>                                   548,937
<CGS>                                              277,759
<TOTAL-COSTS>                                      277,759
<OTHER-EXPENSES>                                         0
<LOSS-PROVISION>                                       664
<INTEREST-EXPENSE>                                  10,882
<INCOME-PRETAX>                                     99,711
<INCOME-TAX>                                        10,498
<INCOME-CONTINUING>                                 88,680
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                    (2,254)
<CHANGES>                                                0
<NET-INCOME>                                        86,426
<EPS-BASIC>                                            .55
<EPS-DILUTED>                                          .53



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission